DOCS vs PRVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

DOCS

45.4
AI Score
VS
DOCS Wins

PRVA

39.9
AI Score

Investment Advisor Scores

DOCS

45score
Recommendation
HOLD

PRVA

40score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric DOCS PRVA Winner
Forward P/E 25.7732 19.4175 PRVA
PEG Ratio 0.5895 0 Tie
Revenue Growth 7.3% 21.4% PRVA
Earnings Growth -51.9% 250.0% PRVA
Tradestie Score 45.4/100 39.9/100 DOCS
Profit Margin 25.5% 1.2% DOCS
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

DOCS 1M: +6.0% · 3M: +29.7% PRVA 1M: +13.6% · 3M: +13.1%

Current Technical Phase

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 54

RSI (14): 54.1 · Price: $32.42

PRVA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 71

RSI (14): 70.7 · Price: $24.37

Fundamentals Snapshot

Metric DOCS PRVA
Market Cap — —
Forward P/E 20.0 23.7
Trailing P/E 45.7 94.4
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.9% 0.1%
Operating Margin 0.3% 0.0%
EPS 0.72 0.26
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DOCS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.